Study design (if review, criteria of inclusion for studies)
Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
Participants
Cystic Fibrosis - 12 Years to 35 Years (Child, Adult)
Interventions
Behavioral: ActivOnline
Outcome measures
Change in physical activity, objectively measures using ActiGrpah GT9X Link accelerometer.|Change in physical activity, subjectively measured using the Habitual Activity Estimation Scale.|Change in forced expiratory volume in one second (FEV1), measured in absolute units (L)|Change in forced vital capacity (FVC), measured in absolute units (L)|Change in forced expiratory volume in one second (FEV1), measured as a percent of predicted, as per GLI2012 equations.|Change in forced vital capacity (FVC), measured as a percent of predicted, as per GLI2012 equations.|Change in exercise attitudes, measured using the Behavioural Regulation in Exercise Questionnaire.|Change in quality of life, measured using age-specific Cystic Fibrosis Questionnaire (Revised).|Change in anxiety, measured using Hospital Anxiety and Depression Scale.|Change in depression, measured using Hospital Anxiety and Depression Scale.|Change in depression, measured using Center for Epidemiological Studies-Depression Scale.|Change in sleep quality, measured using Pittsburgh Sleep Quality Index (PSQI).